Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acute methotrexate toxicity in psoriasis].

A Arévalo-López1

  • 1Servicio de Dermatología, Hospital de Especialidades, CMN Siglo XXI, IMSS, México, D.F.

Gaceta Medica De Mexico
|December 22, 1999
PubMed
Summary

A 71-year-old man experienced severe methotrexate toxicity from a 10 mg daily dose for psoriasis. This case highlights the need for careful patient selection and adherence to guidelines during methotrexate therapy for psoriasis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allergic contact dermatitis to socks presenting as bleached rubber syndrome.

American journal of contact dermatitis : official journal of the American Contact Dermatitis Society·2000
Same author

[Sarcoidosis (intra- and extrathoracic): apropos a Mexican case].

Gaceta medica de Mexico·1991
See all related articles

Area of Science:

  • Dermatology
  • Pharmacology
  • Toxicology

Background:

  • Methotrexate is a common treatment for psoriasis.
  • Patient self-administration of medication can lead to toxicity.
  • Adherence to established treatment guidelines is crucial.

Observation:

  • A 71-year-old male psoriasis patient self-administered 10 mg of methotrexate daily.
  • The patient developed acute methotrexate toxicity.
  • Clinical manifestations included painful psoriatic plaque erosions, stomatitis, bone marrow suppression, and intestinal involvement.

Findings:

  • Acute methotrexate toxicity can manifest with severe mucocutaneous lesions.
  • Systemic involvement, including bone marrow and gastrointestinal tract, can occur.
  • Incorrect dosing or self-administration significantly increases toxicity risk.

Implications:

  • This case underscores the importance of strict patient selection for methotrexate therapy in psoriasis.
  • Physician and patient education on methotrexate dosage and administration is critical.
  • Reinforces the necessity of adhering to established methotrexate treatment protocols to prevent adverse events.

Related Experiment Videos